Jenburkt Pharmaceuticals Ltd. (JENBURPH)
Market Closed
23 Oct, 10:00 AM
XNSE XNSE Primary MSE ₹
870. 95
-0.45
-0.0516%
₹
- Market Cap
20.75 P/E Ratio
- Div Yield
2,340 Volume
0 Eps
₹ 871.4
Previous Close Want to track JENBURPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
JENBURPH closed Friday lower at ₹870.95, a decrease of -0.0516% from Thursday's close, completing a monthly decrease of -5.8534% or -₹54.15. Over the past 12 months, JENBURPH stock lost -16.6635%.
JENBURPH is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
JENBURPH Chart
Jenburkt Pharmaceuticals Ltd. (JENBURPH) FAQ
What is the stock price today?
The current price is ₹870.95.
On which exchange is it traded?
Jenburkt Pharmaceuticals Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is JENBURPH.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Jenburkt Pharmaceuticals Ltd. ever had a stock split?
No, there has never been a stock split.
Jenburkt Pharmaceuticals Ltd. Profile
| Health Care Technology Industry | Healthcare Sector | - CEO | XNSE Exchange | - ISIN |
| India Country | 779 Employees | - Last Dividend | - Last Split | - IPO Date |
Jenburkt Pharmaceuticals Ltd. is a prominent company in the pharmaceutical sector, headquartered in India. Its primary function is to research, manufacture, and market pharmaceutical products and formulations. The company's product portfolio encompasses a wide range of therapeutic categories, including analgesics, antibiotics, cardiology, and dermatology products, among others. Jenburkt Pharmaceuticals Ltd. serves the healthcare industry by supplying essential medicines that contribute to the well-being of patients across India and in various international markets. The firm's commitment to quality and innovation ensures its compliance with pertinent industry standards and regulations. In the financial market, Jenburkt Pharmaceuticals Ltd. plays a significant role as it enables investors to gain exposure to the diverse and continually growing pharmaceutical industry, reflecting on its stability and potential for consistent performance.
Contact Information
Address: Nirmala Apartments
Phone: 91 22 6760 3603
Website: https://jenburkt.com
2026 © Marketlog. All Rights Reserved.
